Strong-smelling urine on Mounjaro: causes, when to act, and what to expect

Why the evidence points to dehydration and reduced intake first

The SURMOUNT-1 trial, published in the New England Journal of Medicine, documented the scale of appetite reduction that tirzepatide produces: participants at the 15 mg dose lost roughly 20–21% of body weight over 72 weeks, which reflects a substantial sustained reduction in caloric intake. That reduction in food and drink volume is the most clinically credible reason for the urine changes people describe. When you eat and drink less, the kidneys produce less urine; the same waste products are dissolved in a smaller volume of water, so the odour becomes more concentrated and noticeable.

The practical picture is straightforward. You pick up your pen from the fridge door on a Sunday morning, take your dose, and over the following days your appetite drops considerably. Coffee consumption falls, meals shrink, and hydration can quietly slip without you noticing. Urine that was pale yellow becomes a deeper amber and carries a sharper smell. That is not the medicine acting on your kidneys, it is the downstream effect of eating and drinking less, which is the medicine working as intended.

Conscious hydration tends to resolve it. Aiming for pale straw-coloured urine (the standard lay indicator of adequate hydration) is a reasonable target. The wider picture of how Mounjaro affects urine covers hydration targets in more detail.

The role of ketones when calorie intake drops sharply

A secondary explanation that matters for some people is ketosis. When calorie intake falls well below maintenance levels, the body increasingly relies on fat oxidation for energy. This process generates ketone bodies, including acetoacetate and beta-hydroxybutyrate, which are filtered through the kidneys and appear in urine. Elevated urinary ketones can produce a sweet, fruity or mildly ammonia-like odour, different from the concentrated smell of dehydration but sometimes described in overlapping terms.

This is not inherently dangerous in the context of a moderate calorie deficit alongside Mounjaro. It is the same mechanism behind the odour changes many people notice when following a very low-calorie or ketogenic diet. The key variable is severity: mild transient ketonuria alongside good hydration is a metabolic response, not a pathology. Persistent heavy ketonuria alongside nausea and vomiting (particularly in anyone with diabetes) is a different matter and warrants medical assessment.

If you are curious about how tirzepatide's dual GIP and GLP-1 receptor mechanism fits into this metabolic picture, our tirzepatide overview explains the pharmacology without the jargon. Understanding the mechanism also helps explain why the effect tends to be more pronounced at the start of treatment and after each dose increase, when appetite suppression is at its sharpest.

Urine changes that are not explained by dehydration or ketones

The vast majority of people who notice a stronger urine odour on Mounjaro are experiencing the two mechanisms above, both of which are benign and manageable. If you want a detailed look at why Mounjaro can affect urine smell and what that means in practice, that page works through the question thoroughly. However, there are changes that sit outside this explanation and require prompt attention.

Blood in urine (whether visible as pink or red discolouration or detected incidentally on a urine dipstick) is not a side effect of tirzepatide and should be reviewed by a GP. Similarly, pain or burning on urination, urgency, cloudy urine alongside fever, or pain in the lower back or flank suggest a urinary tract infection or kidney-related cause that needs investigation regardless of which medicines you are taking. The separate page on blood in urine while on Mounjaro covers that specific scenario in full.

The MHRA's Yellow Card scheme exists for reporting suspected side effects that concern you; patients can submit reports directly. Reporting helps build the safety evidence base for newer medicines like Mounjaro, which carries a Black Triangle (▼) indicating it is subject to additional monitoring. If you have a concern that is not resolving, contact your prescriber, or use the contact page if you are a nume patient.

Putting this in context: what Mounjaro's safety profile actually covers

The recognised side effects of tirzepatide are largely gastrointestinal: nausea, diarrhoea, constipation, indigestion and vomiting are the most common, typically peaking around dose changes before settling. These are direct pharmacological effects, well-documented in clinical trial data and the prescribing information. People sometimes ask specifically whether tirzepatide makes your urine smell, and if so why, and the answer comes back to this same indirect, downstream consequence of the appetite suppression working as intended, rather than tirzepatide acting on the urinary tract.

That distinction matters because it changes how you respond. Nausea from a dose increase gets managed by adjusting eating habits and pacing; concentrated urine gets managed by drinking more water. Neither calls for stopping treatment. What would call for stopping, or at least for urgent clinical review, is covered by the prescriber at each dose review. For a broader look at cost, access and what to expect from a private consultation, our guide to obtaining Mounjaro through a regulated UK pharmacy runs through the process clearly.

If you have questions about starting treatment and want a prescriber to review your situation, you can start a free consultation with the nume team, a GPhC-registered Independent Prescriber reads every submission the same day.